Ammonium Vanadate

Ammonium Vanadate and pregnancy

Not Recommended

• Absorbed into the body
• Fetal development
• Endocrine disruptor

Ammonium vanadate is a vanadium compound used as a pH buffer in cosmetics. Vanadium is a heavy metal with biological activity that can affect cellular processes and hormone signaling. Studies demonstrate that vanadium compounds can cross the placental barrier and accumulate in fetal tissues. Research in animal models shows vanadium exposure during pregnancy can cause developmental abnormalities, reduced birth weight, and skeletal malformations. Vanadium also interferes with thyroid hormone metabolism, which is critical for fetal brain development. The compound's ability to mimic insulin signaling raises concerns about disrupting normal glucose metabolism during pregnancy. While specific regulatory guidance on topical vanadium in pregnancy is limited, toxicology experts recommend avoiding unnecessary exposure to heavy metals during pregnancy due to potential accumulation and developmental risks. Most obstetricians advise pregnant women to minimize contact with compounds that have known endocrine-disrupting properties.

Ammonium Vanadate and breastfeeding

Not Recommended

• Passes into breast milk
• Infant exposure
• Absorbed into the body

Vanadium compounds can be absorbed through the skin and enter systemic circulation. Studies show that vanadium can transfer into breast milk and accumulate in breastfed infants. Research indicates that infants have limited ability to excrete heavy metals, making them particularly vulnerable to accumulation. Vanadium exposure in infants has been associated with developmental concerns and potential neurotoxicity. The compound's endocrine-disrupting properties could interfere with infant thyroid function and growth regulation. Pediatric toxicologists and lactation consultants recommend avoiding cosmetic products containing heavy metal compounds while breastfeeding. The potential risks to infant development outweigh any cosmetic benefits from this buffering agent.

Ammonium Vanadate and postpartum

Not Recommended

• Absorbed into the body
• Endocrine disruptor

For postpartum women not breastfeeding, ammonium vanadate presents concerns related to hormone recovery and thyroid function. The postpartum period involves significant hormonal rebalancing, and exposure to endocrine-disrupting compounds could interfere with this process. Vanadium's effects on thyroid function are particularly relevant postpartum, as many women experience temporary thyroid dysfunction after delivery. Using products with compounds that can further disrupt thyroid hormone metabolism may complicate recovery. While topical exposure is lower than oral intake, the cumulative effect from daily cosmetic use warrants caution during this sensitive period.

Ammonium Vanadate and trying to conceive

Not Recommended

• Fertility effects
• Hormone disruptor
• Builds up in tissue

Women trying to conceive should avoid ammonium vanadate due to vanadium's demonstrated effects on reproductive function. Studies show that vanadium compounds can accumulate in reproductive tissues and interfere with hormone signaling necessary for conception. Research indicates vanadium exposure can affect ovarian function and disrupt the menstrual cycle. The compound's ability to interfere with thyroid hormones is particularly relevant, as optimal thyroid function is essential for fertility. Because vanadium accumulates in tissues over time, discontinuing use only after conception may not eliminate pre-existing body burden. Fertility specialists recommend establishing a clean baseline before attempting conception by avoiding heavy metal exposure for several months beforehand.

Ammonium Vanadate and PCOS

Not Recommended

• Interferes with hormones
• Affects insulin
• Endocrine disruptor

Ammonium vanadate is of particular concern for women with PCOS due to vanadium's known effects on insulin signaling and hormone metabolism. While some oral vanadium supplements have been studied for diabetes management, topical exposure to vanadium compounds in cosmetics presents different risks. Vanadium compounds can interfere with insulin receptor function and glucose metabolism. For women with PCOS who often have insulin resistance, introducing an external compound that affects insulin signaling could complicate metabolic management. Additionally, vanadium's endocrine-disrupting properties may interfere with the delicate hormone balance that PCOS treatments aim to restore. Dermatologists treating PCOS patients generally recommend avoiding products with known hormone-disrupting ingredients. The unpredictable effects of vanadium on insulin and reproductive hormones make it inadvisable for women managing PCOS, especially those on medications targeting these same pathways.

Ammonium Vanadate and general use

Not Recommended

• Absorbed into the body
• Endocrine disruptor
• Common allergen

For the general population, ammonium vanadate presents concerns primarily related to endocrine disruption and potential accumulation with repeated use. Vanadium compounds can penetrate skin and enter systemic circulation, particularly in leave-on products applied to large surface areas. Studies demonstrate that vanadium affects thyroid hormone metabolism, insulin signaling, and cellular oxidative stress. Long-term exposure, even at low levels, can lead to tissue accumulation. Some individuals may also develop contact dermatitis or allergic reactions to vanadium compounds. While acute toxicity from cosmetic use is unlikely, the ECHA and toxicology experts express concern about chronic low-level exposure to heavy metals in personal care products. Many dermatologists recommend choosing products with simpler, better-studied buffering agents rather than heavy metal compounds.

Everything else flagged for the same profiles

• Flagged in pregnancy
• Flagged in breastfeeding
• Flagged in trying to conceive
• Flagged in postpartum
• Flagged in PCOS

Related ingredients

Ingredients that raise the same concerns.

• Hydrastis Canadensis ExtractAffects insulin, Fertility effects, Interferes with hormones
• sh-Polypeptide-16Affects insulin, Interferes with hormones, Fetal development
• TBHQEndocrine disruptor, Builds up in tissue, Fertility effects
• Nonoxynol-20Endocrine disruptor, Builds up in tissue, Fertility effects
• 4-Methylbenzylidene CamphorEndocrine disruptor, Builds up in tissue, Fertility effects
• Perfluorooctyl TriethoxysilaneEndocrine disruptor, Builds up in tissue, Fertility effects

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on 15 September 2026.